Publications by authors named "Mizokami Masashi"

Regular monitoring of patients with a history of hepatitis C virus (HCV) infection is critical for the detection and management of hepatocellular carcinoma (HCC). Mac-2 binding protein glycosylation isomer (M2BPGi) has been used to monitor fibrosis progression and predict HCC. However, HCC prediction based on M2BPGi has not been optimized.

View Article and Find Full Text PDF

The integrative multi-kingdom interaction of the gut microbiome in ulcerative colitis (UC) and Crohn's disease (CD) remains underinvestigated. Here, we perform shotgun metagenomic sequencing of feces from patients with UC and CD, and healthy controls in the Japanese 4D cohort, profiling bacterial taxa, gene functions, and antibacterial genes, bacteriophages, and fungi. External metagenomic datasets from the US, Spain, the Netherlands, and China were analyzed to validate our multi-biome findings.

View Article and Find Full Text PDF

This study aimed to identify biomarkers to distinguish adult-onset Still's disease (AOSD) and to predict disease phenotypes. In total, 49 patients diagnosed with AOSD and 200 patients with common diseases (controls) were included in the analysis. The levels of 69 cytokines were analyzed using a multi-suspension cytokine array.

View Article and Find Full Text PDF
Article Synopsis
  • - The study investigates how the expression of Mac-2 binding protein (M2BP) in the liver relates to fat accumulation and changes in the liver environment in patients with metabolic dysfunction associated steatotic liver disease (MASLD).
  • - Liver samples from 46 MASLD patients were analyzed for M2BP expression using immunohistochemical staining, revealing a higher M2BP staining grade in sinusoidal cells compared to hepatocytes, and a correlation between hepatocyte staining and liver inflammation.
  • - Results indicate that fat accumulation triggers M2BP expression linked to liver inflammation in hepatocytes and fibrosis in sinusoidal cells, suggesting a complex role of M2BP in MASLD pathology.
View Article and Find Full Text PDF
Article Synopsis
  • The study investigates serum caspase-1 levels as a potential inflammatory biomarker in patients with adult-onset Still's disease (AOSD), comparing it with rheumatoid arthritis (RA) patients and healthy controls (HCs).
  • Findings show that AOSD patients have significantly higher serum caspase-1 levels than RA patients and HCs, with strong correlations between caspase-1 levels and AOSD disease activity, alongside key inflammatory cytokines.
  • The results suggest that caspase-1 could serve as a valuable biomarker for diagnosing and monitoring AOSD, indicating its role in the disease's inflammatory processes through inflammasome activation.
View Article and Find Full Text PDF

A transfusion-transmitted hepatitis B virus (HBV) infection caused by blood only positive for anti-hepatitis B surface antigen (anti-HBs) was reported. Occult HBV infection (OBI) with sole anti-HBs among blood donors is an issue. The incidence of HBV infection among repeat blood donors was investigated with a detailed HBV infection phase, focusing on the influence of anti-HBs level.

View Article and Find Full Text PDF
Article Synopsis
  • A 67-year-old Japanese woman with liver cirrhosis from primary biliary cholangitis was admitted to the hospital after losing consciousness.
  • She was diagnosed with hepatic encephalopathy (HE) through imaging and symptoms assessment.
  • Molecular tests showed a link between urease-positive S. salivarius found in her saliva and stool, suggesting it may contribute to increased ammonia production and subsequent HE in cirrhosis patients.
View Article and Find Full Text PDF
Article Synopsis
  • Adult-onset Still's disease (AOSD) may involve autoinflammation and cytokine imbalance, with the study focusing on the relationship between galectin-3 (Gal-3), a specific protein, and multiple cytokines in Japanese AOSD patients.
  • The study included 44 AOSD patients, alongside controls with rheumatoid arthritis and healthy individuals, measuring serum levels of Gal-3, M2BPGi, and 69 cytokines to identify patterns and correlations.
  • Results revealed significantly elevated levels of Gal-3 and M2BPGi in AOSD patients, with Gal-3 linked to disease activity and various inflammatory cytokines, and immunosuppressive treatment effectively lowering the levels of both
View Article and Find Full Text PDF

Clinical and biochemical features of hepatitis delta virus (HDV) infections in Mongolia remain largely unknown. We aimed to investigate the clinical characteristics of HDV patients in Mongolia using several markers. The 143 hepatitis B surface antigen (HBsAg)-positive patients were divided into 122 HDV-positive and 21 HDV-negative patients by HDV RNA positivity.

View Article and Find Full Text PDF

Background: The relationship between liver fibrosis and inflammation and Mac-2-binding protein glycosylation isomer (M2BPGi) in patients with chronic liver disease (CLD) other than hepatitis C remains uncertain, owing to the limitations of qualitative methods. Here, we evaluated the influence of liver fibrosis and inflammation on quantitative M2BPGi (M2BPGi-Qt) in CLD, considering each etiology.

Methods: We recruited 1373 patients with CLD.

View Article and Find Full Text PDF
Article Synopsis
  • * M2BPGi, secreted by cancer-associated fibroblasts, enhances the growth and invasion of PC cells, independent of galectin-3 suppression.
  • * Reducing M2BPGi levels in mice with PC led to smaller tumors and increased effectiveness of the chemotherapy drug gemcitabine, suggesting it could be a new treatment approach for PC.
View Article and Find Full Text PDF

Monitoring of hepatitis B virus (HBV)-DNA and HBV-DNA-guided preemptive therapy using nucleos(t)ide analogs (NAs) are recommended to prevent the development of hepatitis due to HBV reactivation after allogeneic hematopoietic stem cell transplantation (allo-HSCT) in recipients with resolved HBV infection. However, little is known about the appropriate duration of NA treatment and the effect of NA cessation on the recurrence of HBV reactivation. This study aimed to clarify the consequences of NA cessation in allo-HSCT recipients with resolved HBV infection who experienced HBV reactivation following transplantation.

View Article and Find Full Text PDF

Background: Recent clinical studies have suggested that the risk of developing HCC might be lower in patients with chronic hepatitis B receiving tenofovir disoproxil fumarate than in patients receiving entecavir, although there is no difference in biochemical and virological remission between the 2 drugs.

Methods: The effects of nucleoside analogs (NsAs; lamivudine and entecavir) or nucleotide analogs (NtAs; adefovir disoproxil, tenofovir disoproxil fumarate, and tenofovir alafenamide) on cell growth and the expression of growth signaling molecules in hepatoma cell lines and PXB cells were investigated in vitro. The tumor inhibitory effects of NsAs or NtAs were evaluated using a mouse xenograft model, and protein phosphorylation profiles were investigated.

View Article and Find Full Text PDF

The Japanese archipelago is a terminal location for human migration, and the contemporary Japanese people represent a unique population whose genomic diversity has been shaped by multiple migrations from Eurasia. We analyzed the genomic characteristics that define the genetic makeup of the modern Japanese population from a population genetics perspective from the genomic data of 9,287 samples obtained by high-coverage whole-genome sequencing (WGS) by the National Center Biobank Network. The dataset comprised populations from the Ryukyu Islands and other parts of the Japanese archipelago (Hondo).

View Article and Find Full Text PDF
Article Synopsis
  • This study evaluated a new chemiluminescent enzyme immunoassay for measuring Mac-2 binding protein glycosylation isomer (M2BPGi) levels in patients with hepatitis C virus (HCV) and healthy volunteers in Japan.
  • The new quantitative measurement system demonstrated strong reproducibility and correlation with traditional semi-quantitative methods, showing reliable results across a range of M2BPGi levels.
  • The conclusion indicates that the quantitative method reduces interpretation bias and provides more precise measurements, especially at higher M2BPGi levels compared to qualitative methods.
View Article and Find Full Text PDF

The Kelch-like ECH-associated protein 1 (Keap1)/NF-E2-related factor 2 (Nrf2)/antioxidant response element (ARE) signaling pathway is one of the most important defense mechanisms against oxidative stress. We previously reported that a cellular hydrogen peroxide scavenger protein, peroxiredoxin 1, a target gene of transcription factor Nrf2, acts as a novel HBV X protein (HBx)-interacting protein and negatively regulates hepatitis B virus (HBV) propagation through degradation of HBV RNA. This study further demonstrates that the Nrf2/ARE signaling pathway is activated during HBV infection, eventually leading to the suppression of HBV replication.

View Article and Find Full Text PDF

Aim: Reports of patients with hepatitis B have highlighted associations between polymorphisms in the human leukocyte antigen (HLA)-DPB1, CXCL13, and CXCR5 genes and disease pathology. Owing to its potential to contribute to the development of new diagnostic and therapeutic methods, we aimed to establish a reliable host genome analysis technique that can be used in countries with inadequate infrastructure.

Method: We compared multiple commercially available kits for dried blood spot (DBS)-based sample collection to develop a basic DBS-based host genome analysis technique.

View Article and Find Full Text PDF

Aim: We performed genomic analysis to study the relative abundance of a urease-positive Streptococcus salivarius group isolated from the saliva of patients with chronic liver disease.

Methods: Male and female patients with chronic liver disease aged over 20 years were included. First, we assessed the frequency and type of the S.

View Article and Find Full Text PDF

Hepatitis B virus (HBV) is a life-threatening infectious virus associated with the risk of liver failure and hepatocellular carcinoma (HCC). Regarding HBV treatment, the recent development of nucleoside/nucleotide analogs (NUC), HBV reverse transcriptase inhibitors, enabled favorable viral control as well as improved prognosis in patients with chronic hepatitis B. However, NUC fails to clear HBV because the formation of covalently closed circular DNA or HBV surface antigen occurs upstream of the point of action of NUC.

View Article and Find Full Text PDF

The development of liver cancer in patients with hepatitis B is a major problem, and several models have been reported to predict the development of liver cancer. However, no predictive model involving human genetic factors has been reported to date. For the items incorporated in the prediction model reported so far, we selected items that were significant in predicting liver carcinogenesis in Japanese patients with hepatitis B and constructed a prediction model of liver carcinogenesis by the Cox proportional hazard model with the addition of () genotypes.

View Article and Find Full Text PDF
Article Synopsis
  • BRAF mutations, particularly BRAF V600E, are common in colorectal cancers, but a new mutation, BRAF L525R, was identified and studied for its effects on cancer cell behavior.
  • The study utilized HEK293 cells with BRAF V600E or L525R mutations, testing their response to various cancer treatments and assessing cell viability and signaling pathways.
  • Results indicated that selumetinib effectively inhibited cell growth and ERK activation in BRAF L525R cells, while the AKT pathway played a crucial role in determining sensitivity and resistance to this treatment.
View Article and Find Full Text PDF
Article Synopsis
  • Hepatitis B virus (HBV) is a widespread chronic infection in Japan, predominantly involving genotypes B and C, but there's been a gradual increase in genotype A cases over the years.
  • A nationwide survey included 4,421 chronic hepatitis B (CHB) patients to analyze the distribution of HBV genotypes and their trends across different age groups from 2000-2016.
  • Results showed that while the overall prevalence of genotype A remained stable, it rose among younger adults; meanwhile, genotypes B and C shifted to older populations, highlighting the need for future studies on the impact of Japan's universal HBV vaccination introduced in 2016.
View Article and Find Full Text PDF

Background & Aims: We investigate interrelationships between gut microbes, metabolites, and cytokines that characterize COVID-19 and its complications, and we validate the results with follow-up, the Japanese 4D (Disease, Drug, Diet, Daily Life) microbiome cohort, and non-Japanese data sets.

Methods: We performed shotgun metagenomic sequencing and metabolomics on stools and cytokine measurements on plasma from 112 hospitalized patients with SARS-CoV-2 infection and 112 non-COVID-19 control individuals matched by important confounders.

Results: Multiple correlations were found between COVID-19-related microbes (eg, oral microbes and short-chain fatty acid producers) and gut metabolites (eg, branched-chain and aromatic amino acids, short-chain fatty acids, carbohydrates, neurotransmitters, and vitamin B6).

View Article and Find Full Text PDF
Article Synopsis
  • The study compares the incidence of hepatocellular carcinoma (HCC) in patients treated with two different therapies for hepatitis C: sofosbuvir/ledipasvir (SOF/LDV) and simeprevir with pegylated interferon plus ribavirin (Sim+IFN).
  • Both groups were monitored for 5 years after achieving a sustained virological response (SVR), with similar rates of HCC observed—9 cases in the SOF/LDV group and 7 in the Sim+IFN group.
  • The findings suggest that both treatments do not significantly differ in HCC incidence and indicate that the development of HCC was likely due to pre-existing conditions rather than the therapies themselves.
View Article and Find Full Text PDF
Article Synopsis
  • The study investigates the quasispecies composition of hepatitis C virus (HCV) in patients, which may affect how the virus behaves and responds to treatments.
  • Researchers developed a method using next-generation sequencing to identify different HCV genome sequences present in a single patient's serum over time.
  • The findings revealed that multiple dominant viral species can coexist in a patient's serum and evolve independently, highlighting the complexity of HCV infection management.
View Article and Find Full Text PDF